Theravance Biopharma TBPH
NASDAQ TBPH
$17.03 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

Theravance Biopharma (TBPH) Price to FCF (2025 - 2026)

Updated

Theravance Biopharma's (TBPH) Price to FCF came in at 16.42 for Q2 2026, up 623.5% from 2.27 a year earlier and up 427.7% from the prior quarter.

Analysis

Theravance Biopharma (TBPH) Price to FCF (2025 - 2026) Analysis & Trends

For FY2025, Theravance Biopharma's Price to FCF stood at 4.01.

  • According to Business Quant data, Price to FCF for the three prior quarters was 3.11 (Q1 2026), 4.01 (Q4 2025) and 3.04 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Theravance Biopharma 883.70 Mn -543.66 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16.42
Mar 31, 2026 3.11
Dec 31, 2025 4.01
Sep 30, 2025 3.04
Jun 30, 2025 2.27
Mar 31, 2025 13.83
API Access

Theravance Biopharma Price to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-fcf&ticker=TBPH&period=max&api_key=YOUR_API_KEY